NYU Langone Health | Alpha Leaders

Browsing: NYU Langone Health

How big data and an A-list board turned struggling NYU Langone into a billion hospital powerhouse

How big data and an A-list board turned struggling NYU Langone into a $14 billion hospital powerhouse

By Press Room19 August 2025

On a rainy afternoon in May, the 96 members of New York University Grossman School of Medicine, Class of 2025,…

NYU Langone Super Bowl Ad Claimed “We’re #1,” But Where’s Scorecard?

By Press Room15 February 2025

When the Philadelphia Eagles thrashed the Kansas City Chiefs 40-22 in Super Bowl LIX, no one disputed that they sat…

Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows

By Press Room20 December 2024

Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in…

Patients are so sick and tired of waiting years for a transplant that they’re signing up in droves to receive vital organs from pigs

By Press Room17 December 2024

On a farm in the southern US state of Virginia, David Ayares and his research teams are breeding genetically modified…

Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds

By Press Room4 December 2024

Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables. Zepbound (tirzepatide), manufactured…

What's On

AI investment pressures, supply-chain risks, and strategy misalignment are all on the line for CFOs

Rivian CEO says the EV maker’s new large driving model could land them a spot in robotaxi race

Ex Meta integrity chief says new report reveals ‘disappointing’ ad fraud epidemic at the tech giant

Browsing: NYU Langone Health

How big data and an A-list board turned struggling NYU Langone into a $14 billion hospital powerhouse

NYU Langone Super Bowl Ad Claimed “We’re #1,” But Where’s Scorecard?

Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows

Patients are so sick and tired of waiting years for a transplant that they’re signing up in droves to receive vital organs from pigs

Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds

Unwrap Christmas Sustainably: How To Handle Gifts You Don’t Want

Walmart dominated, while Target spiraled: the winners and losers of retail in 2024

John Summit went from working 9 a.m. to 9 p.m. in a $65,000 job to a multimillionaire DJ—‘I make more in one show than I would in my entire accounting career’

Morgan Stanley strategist Michael Wilson says lackluster job numbers could actually be good news

‘I had to take 60 meetings’: Jeff Bezos says ‘the hardest thing I’ve ever done’ was raising the first million dollars of seed capital for Amazon

What happens to old AI chips? They’re still put to good use and don’t depreciate that fast

Chaos At The FDA Benefits America’s Rivals—At The Expense Of America’s Patients

Our Picks

AI investment pressures, supply-chain risks, and strategy misalignment are all on the line for CFOs

Rivian CEO says the EV maker’s new large driving model could land them a spot in robotaxi race

Ex Meta integrity chief says new report reveals ‘disappointing’ ad fraud epidemic at the tech giant

Most Popular

New York Approves Casino Sites—With Trump And Billionaire Steve Cohen Standing To Gain

Morgan Stanley strategist Michael Wilson says lackluster job numbers could actually be good news

‘I had to take 60 meetings’: Jeff Bezos says ‘the hardest thing I’ve ever done’ was raising the first million dollars of seed capital for Amazon